Muna Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Series B
- (Cancelled)
- Investors
-
12
Muna Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to discover neurodegenerative therapies. The company's platform identifies new medicines to preserve cognition and other brain functions and operational resilience against neurodegenerative diseases, including Alzheimer's, frontotemporal dementia, and Parkinson's, enabling medical companies to help people suffering from neurodegenerative diseases access suitable therapeutics for rapid recovery.
Contact Information
Website
www.munatherapeutics.comCorporate Office
- Nordre Fasanvej 215
- 2000 Frederiksberg
- Denmark
Corporate Office
- Nordre Fasanvej 215
- 2000 Frederiksberg
- Denmark
Muna Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 15-Oct-2025 | Cancelled | Generating Revenue | |||
| 5. Grant | 01-May-2026 | Completed | Generating Revenue | |||
| 4. Grant | 11-Oct-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 09-Jul-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 31-Dec-2020 | $6.05M | $6.05M | Completed | Startup | |
| 1. University Spin-Out | 22-Jan-2020 | Completed | Startup |
Muna Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 14,652 | $54.84 | $54.84 | 1x | $54.84 | 1.09% | ||
| Ordinary | 121,904 | $42.19 | $42.19 | 1x | $42.19 | 9.09% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Muna Therapeutics Comparisons
Industry
Financing
Details
Muna Therapeutics Competitors (3)
One of Muna Therapeutics’s 3 competitors is Neuropore Therapies, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuropore Therapies | Corporation | San Diego, CA | ||||
| Denali Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Inhibikase Therapeutics | Corporation | Wilmington, DE |
Muna Therapeutics Patents
Muna Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026099455-A1 | Dihydropyrrolopyrimidinone compounds as trem2 modulators | Pending | 08-Nov-2024 | ||
| WO-2025191114-A1 | Trem2 modulators | Pending | 14-Mar-2024 | ||
| WO-2025191115-A1 | Trem2 modulators | Pending | 14-Mar-2024 | ||
| WO-2025157993-A1 | Trem2 modulators | Pending | 24-Jan-2024 | ||
| EP-4836962-A1 | 2-(tetrahydro-2h-pyran-4-yl)-7-methyl-8-oxo-6-(trifluoromethyl)-7,8-dihydropyrimido[5,4-d]pyrimidine derivatives as trem2 modulators for the treatment of neurodegenerative diseases | Pending | 04-Jan-2024 | C07D487/04 |
Muna Therapeutics Signals
Muna Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alzheimer's Association | Corporation | |||
| VLAIO | Limited Partner | |||
| Michael J. Fox Foundation | Limited Partner | |||
| Droia Ventures | Venture Capital | Minority | ||
| EQT Life Sciences | Venture Capital | Minority |
Muna Therapeutics FAQs
-
When was Muna Therapeutics founded?
Muna Therapeutics was founded in 2020.
-
Where is Muna Therapeutics headquartered?
Muna Therapeutics is headquartered in Frederiksberg, Denmark.
-
What is the size of Muna Therapeutics?
Muna Therapeutics has 19 total employees.
-
What industry is Muna Therapeutics in?
Muna Therapeutics’s primary industry is Drug Discovery.
-
Is Muna Therapeutics a private or public company?
Muna Therapeutics is a Private company.
-
What is Muna Therapeutics’s current revenue?
The current revenue for Muna Therapeutics is .
-
How much funding has Muna Therapeutics raised over time?
Muna Therapeutics has raised $85.1M.
-
Who are Muna Therapeutics’s investors?
Alzheimer's Association, VLAIO, Michael J. Fox Foundation, Droia Ventures, and EQT Life Sciences are 5 of 12 investors who have invested in Muna Therapeutics.
-
Who are Muna Therapeutics’s competitors?
Neuropore Therapies, Denali Therapeutics, and Inhibikase Therapeutics are competitors of Muna Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process